p16 (INK4a, MTS‐1) gene polymorphism and methylation status in human pituitary tumours
Authors:
- 1 September 1999
- journal article
- research article
- Published by Wiley in Clinical Endocrinology
- Vol. 51 (3) , 317-325
Abstract
OBJECTIVE The p16 gene, which encodes a physiological inhibitor of the cyclin D‐CDK4 complex, is now considered as an important tumour‐suppressor gene in a variety of tumours. A marked reduction of ...Keywords
This publication has 30 references indexed in Scilit:
- Frequent inactivation of thep16 gene in human pituitary tumors by gene methylationMolecular Carcinogenesis, 1997
- Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4aCell, 1997
- Cellular receptors for sex steroids in human pituitary adenomasJournal of Endocrinology, 1996
- Mutations associated with familial melanoma impair p16INK4 functionNature Genetics, 1995
- p53 gene mutations in pituitary adenomas: rare eventsClinical Endocrinology, 1994
- Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colonNature Genetics, 1994
- A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor TypesScience, 1994
- A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4Nature, 1993
- Association of somatotrophinomas with loss of alleles on chromosome 11 and with gsp mutations.Journal of Clinical Investigation, 1993
- Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms.Proceedings of the National Academy of Sciences, 1989